|
|
||||||||
Division of Nuclear Medicine, Department of Radiology, Emory University School of Medicine and Department of Chemistry, Emory University, Atlanta, Georgia
Correspondence: For correspondence or reprints contact: Andrew Taylor, Jr., MD, Division of Nuclear Medicine, Department of Radiology, Emory University School of Medicine, 1364 Clifton Rd., Atlanta, GA 30322.
ABSTRACT
Technetium-99m-L,L-ethylenedicysteine (99mTc-L,L-EC)is a new renal imaging agent with pharmacokinetic properties reported to be slightly superior to those of 99mTc-mercaptoacetyltriglycine (99mTc MAG3); however, to better define the potential of the enantiomer 99mTc-DD-EC and the diastereomer 99mTc-DL-EC as renal imaging agents, we compared the three EC stereoisomers with 131I-orthoiodohippurate (OIH) in a series of rats and humans. Methods: Each 99mTc-EC stereoisomer was coinjected with OIH in six Sprague-Dawley rats for measurements of clearance and extraction fraction. Each stereoisomer was also coinjected wfth OIH in three human volunteers followed by sequential imaging, plasma clearance measurements and timed urine collections. Results: Technetium-99m-DD-EC had the highest clearance and extraction efficiency in rats (p
0.02). In humans, image quality was good with all three agents. The clearance ratio (EC/OIH) was 82% ± 8% for 99mTc-DD-EC compared to 70% ± 3% and 40% ± 5% for 99mTc-L,L-EC and 99mTc-DL-EC, respectivaly. Technetium-99m-DD and 99mTc-L,L-EC were excreted more rapidly than 99mTc-DL-EC. Conclusion: Technetium-99m-DD-EC has excellent imaging properties and the data suggest that its clearance may approach that of OIH more closely than any other 99mTc renal agent. A potential limitationis the fact that both 99mTc-DD and LL-EC exist in dianionic (80%) and monoanionic (20%) forms at physiological pH and it is unlikely that these two forms have the same clearance or protein binding affinity.
Key Words: technetium-99m-DD-EC technetium-99m-L,L-EC tectinetium-99m-DL-EC renal scintigraphy
This article has been cited by other articles:
![]() |
M. Lipowska, H. He, E. Malveaux, X. Xu, L. G. Marzilli, and A. Taylor First Evaluation of a 99mTc-Tricarbonyl Complex, 99mTc(CO)3(LAN), as a New Renal Radiopharmaceutical in Humans J. Nucl. Med., June 1, 2006; 47(6): 1032 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Taylor, M. Lipowska, L. Hansen, E. Malveaux, and L. G. Marzilli 99mTc-MAEC Complexes: New Renal Radiopharmaceuticals Combining Characteristics of 99mTc-MAG3 and 99mTc-EC J. Nucl. Med., May 1, 2004; 45(5): 885 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Eshima, L. Eshima, L. Hansen, M. Lipowska, L. G. Marzilli, and A. Taylor Jr Effect of Protein Binding on Renal Extraction of 131I-OIH and 99mTc-Labeled Tubular Agents J. Nucl. Med., December 1, 2000; 41(12): 2077 - 2082. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |